NCT01409005 - Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 28, 2013

Conditions

Metastatic or Recurrent Colorectal CancerRefractory to Fluoropyrimidine, Oxaliplatin and IrinotecanSalvage Chemotherapy

Interventions

DRUG

Gemcitabine and UFTE chemotherapy

"Gemcitabine : 800 mg/m2 mix with 150mL of normal saline (i.v.) over 30 min on Days 1, 8 and 15~UFTE : 200mg/m2 PO q 8 hr, Days 1\~21~Interval: every 4 weeks"

Trial Locations (3)

463-707

Seoul National University Bundang Hospital, Seongnam-si

Unknown

Seoul National University Hospital, Seoul

SMG-SNU Boramae Medical Center, Seoul